Fast-Killing Tyrosine Amide ((<i>S</i>)-SW228703) with Blood- and Liver-Stage Antimalarial Activity Associated with the Cyclic Amine Resistance Locus (<i>Pf</i>CARL)-Reference-Cited by-同舟云学术

Fast-Killing Tyrosine Amide ((S)-SW228703) with Blood- and Liver-Stage Antimalarial Activity Associated with the Cyclic Amine Resistance Locus (PfCARL)

Published:2023-02-10 Issue:3 Volume:9 Page:527-539
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Imlay Leah S.^ORCID,Lawong Aloysus K.,Gahalawat Suraksha,Kumar Ashwani^ORCID,Xing Chao^ORCID,Mittal Nimisha¹,Wittlin Sergio²³^ORCID,Churchyard Alisje⁴,Niederstrasser Hanspeter,Crespo-Fernandez Benigno⁵^ORCID,Posner Bruce A.,Gamo Francisco-Javier⁵^ORCID,Baum Jake⁴⁶,Winzeler Elizabeth A.¹^ORCID,Laleu Benoît⁷^ORCID,Ready Joseph M.^ORCID,Phillips Margaret A.^ORCID

Affiliation:

1. Division of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093, United States

2. Swiss Tropical and Public Health Institute, 4002 Basel, Switzerland

3. University of Basel, 4002 Basel, Switzerland

4. Department of Life Sciences, Imperial College London, London SW7 2AZ, U.K.

5. Global Health Medicines, GlaxoSmithKline R&D, Tres Cantos, 28760 Madrid, Spain

6. School of Biomedical Sciences, University of New South Wales, Kensington, NSW 2052, Australia

7. Medicines for Malaria Venture, 1215 Geneva 15, Switzerland

Funder

Welch Foundation

National Institute of Allergy and Infectious Diseases

Wellcome Trust

Medicines for Malaria Venture

National Institute of General Medical Sciences